Rakuten医学和LOTTE生物logics伙伴制造全球肿瘤药物,促进癌症治疗的获得。 Rakuten Medical and LOTTE Biologics partner to manufacture global oncology drugs, advancing cancer treatment access.

Rakuten医学和LOTTE生物logics签订了一项制造协议,为旨在推进癌症治疗的全球肿瘤学方案生产生物药剂。 Rakuten Medical and LOTTE Biologics have entered a manufacturing agreement to produce biopharmaceuticals for a global oncology program, aiming to advance cancer treatments. 这一伙伴关系将利用LOTTE的生产能力支持创新疗法的发展和分配,最初的重点是下一代癌症药物。 The partnership will leverage LOTTE’s production capabilities to support the development and distribution of innovative therapies, with initial focus on next-generation cancer drugs. 合作标志着在扩大全世界获得尖端肿瘤治疗机会方面迈出的关键一步。 The collaboration marks a key step in expanding access to cutting-edge oncology treatments worldwide.